Search results
21 sie 2018 · The USPSTF found convincing evidence that screening with cervical cytology alone, primary testing for high-risk HPV types (hrHPV testing) alone, or in combination at the same time (cotesting) can detect high-grade precancerous cervical lesions and cervical cancer.
The adoption of the USPSTF guidelines expands the recommended options for cervical cancer screening in average-risk individuals aged 30 years and older to include screening every 5 years with primary high-risk human papillomavirus (hrHPV) testing.
10 mar 2022 · Cervical Cancer: Screening. An Update for This Topic is In Progress. LAST UPDATED: Mar 10, 2022. The Task Force keeps recommendations as current as possible by routinely updating existing recommendations and developing new recommendations. A multistep process is followed for each recommendation.
21 sie 2018 · Screening with cervical cytology alone, primary testing for hrHPV alone, or both at the same time (cotesting) can detect high-grade precancerous cervical lesions and cervical cancer. Clinicians should focus on ensuring that women receive adequate screening, appropriate evaluation of abnormal results, and indicated treatment, regardless of which ...
Links and resources related to cervical screening, management, and colposcopy guidelines and recommendations. USPSTF Screening Guidelines. ASCCP endorses the United States Preventative Services Task Force (USPSTF) cervical cancer screening guidelines. View Guidelines.
In 2018, the U.S. Preventive Services Task Force (USPSTF) recommended primary human papillomavirus (HPV) testing without cytology as an option for cervical cancer screening.
Cervical Cancer Screening Guidelines (2020) Created by the American Cancer Society. Access the full text of current ACS screening recommendations (and rationale) for prevention and early detection of cervical cancer.
